On the therapeutic potential for insulin-like growth factor use in motor neuron disease.
Ishii
D N
DN
Department of Physiology, Colorado State University, Fort Collins 80523.
Marsh
D J
DJ
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology; D015870:Gene Expression; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis / Q000502:physiology / Q000627:therapeutic use*; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis / Q000502:physiology / Q000627:therapeutic use*; D016472:Motor Neuron Disease / Q000188:drug therapy* / Q000503:physiopathology; D009416:Nerve Regeneration / Q000187:drug effects
D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II